Insights in Infectious Agents and Disease: 2022
Insights in Infectious Agents and Disease: 2022

Author: Axel Cloeckaert

Publisher: Frontiers Media SA

Published: 2024-07-18

Total Pages: 550

ISBN-13: 2832551912

DOWNLOAD EBOOK

We are now entering the third decade of the 21st Century, and, especially in the last years, the achievements made by scientists in the field of Microbiology have been exceptional, leading to major advancements. Frontiers has organized a series of Research Topics to highlight the latest advancements in science in order to be at the forefront of science in different fields of research. This specific editorial initiative, led by Dr. Axel Cloeckaert is focused on new insights, novel developments, current challenges, latest discoveries, recent advances and future perspectives in the field. The Research Topic solicits brief, forward-looking contributions from the editorial board members that describe the state of the art, outlining recent developments and major achieved accomplishments, future challenges and how to address those challenges to move the field forward. Reviews, Mini-Reviews, Perspectives, and Opinions summarizing the current state and future directions of the field are particularly welcome in this collection.

Disease Control Priorities, Third Edition (Volume 6)
Disease Control Priorities, Third Edition (Volume 6)

Author: King K. Holmes

Publisher: World Bank Publications

Published: 2017-11-06

Total Pages: 1027

ISBN-13: 1464805253

DOWNLOAD EBOOK

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

Clinical Tuberculosis
Clinical Tuberculosis

Author: Peter D. O. Davies

Publisher: CRC Press

Published: 2014-04-30

Total Pages: 482

ISBN-13: 0429586493

DOWNLOAD EBOOK

Completely updated and revised, Clinical Tuberculosis continues to provide the TB practitioner-whether in public health, laboratory science or clinical practice-with a synoptic and definitive account of the latest methods of diagnosis, treatment and control of this challenging and debilitating disease.New in the Fifth Edition:Gamma interferon-based

Oral Cephalosporins
Oral Cephalosporins

Author: Robert C. Moellering

Publisher: S Karger Ag

Published: 1995

Total Pages: 0

ISBN-13: 9783805561631

DOWNLOAD EBOOK

This volume provides an excellent survey of the chemistry, microbiology, pharmacology and clinical use of the oral cephalosporins in general and the newer agents in particular. The cephalosporins have long provided satisfactory treatment for many disorders without causing serious side effects; and over the past fifty years forms with different antimicrobial, pharmacologic and toxicologic properties have been developed. Despite the broad spectrum of their activity against a large variety of gram-positive and gram-negative bacteria, the third-generation oral cephalosporins including the prodrug esters do not work against Pseudomonas aeruginosa, methicillin-resistant staphylococci, enterococci or Bacteroides species. Many, however, are suitable for treating infections of the respiratory and urinary tracts and of the skin and its structure, as well as certain sexually-transmitted diseases. Authors consider other possible uses, against multi-resistant Enterobacteriaceae for instance, but also point out the limitations of the oral cephalosporins. For those working in the fields of infectious disease, bacteriology, chemotherapy, pharmaceutics and pharmacokinetics, this book is a valuable source of authoritative information.

Modeling the Transmission and Prevention of Infectious Disease
Modeling the Transmission and Prevention of Infectious Disease

Author: Christon J. Hurst

Publisher: Springer

Published: 2017-08-31

Total Pages: 290

ISBN-13: 3319606166

DOWNLOAD EBOOK

This volume focuses on blocking disease transmission and the ecological perspective of pathogens and pathogenic processes. The chapters on blocking transmission cover the environmental safety of space flight, biocides and biocide resistance, as well as infection control in healthcare facilities. The book also offers insights into the ecological aspects of infectious disease, introducing the reader to the role of indigenous gut microbiota in maintaining human health and current discussions on environmentally encountered bacterial and fungal pathogens including species that variously cause the necrotizing skin disease Buruli ulcer and coccidioidomycosis. Further, it explores the influenza A virus as an example for understanding zoonosis. It is a valuable resource for microbiologists and biomedical scientists alike.

Growing Physician Leaders
Growing Physician Leaders

Author: Mark Hertling

Publisher: RosettaBooks

Published: 2016

Total Pages: 0

ISBN-13: 9780795348082

DOWNLOAD EBOOK

Physicians hold the key to improving healthcare, but few doctors get trained in the leadership necessary to turn it. Gen. Mark Hertling applies his four decades of military leadership to the world of healthcare, resulting in profoundly constructive training that can help doctors reshape and reenergize any healthcare organization in America today.

Immunotherapies Against Infectious Diseases
Immunotherapies Against Infectious Diseases

Author: Saba Tufail

Publisher: Frontiers Media SA

Published: 2024-06-06

Total Pages: 115

ISBN-13: 2832550029

DOWNLOAD EBOOK

Infectious diseases have jeopardized human health significantly as evidenced by the ongoing Covid-19 pandemic. In recent years, the world has witnessed outbreaks of many emerging and re-emerging infections such as SARS (most recent by SARS-CoV-2), Ebola, Zika, MERS, dengue which in addition to taking millions of lives, have posed major health issues in recovered individuals. Moreover, several infectious agents like hepatitis B and C viruses, human papillomavirus, human immunodeficiency virus type 1, Epstein-Barr virus, human T-cell leukemia/lymphoma virus type 1, Kaposi sarcoma-associated herpesvirus, Helicobacter pylori and Streptococcus bovis have been found to cause different types of cancers since the action mechanism of these agents sometimes transforms an infected cell into a cancer cell. As these infections are difficult to treat with available drugs owing to their lower efficacy, toxicity and emergence of drug resistance; immunotherapy is viewed as a viable option.